StreetAlpha.app
Home › Stocks › CTEV

Claritev Corp (CTEV)

$22.92
▼ −8.45%
LAST CLOSE · NOV 17

Claritev provides healthcare claims, pricing and data analytics services to health plans and other payers. It last closed at $22.92 on Nov 17, down 8.45% on the day. CTEV last reported earnings on Fri, Aug 7, 2026.

AI Auto Pilots
Is CTEV in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$1.0B
+6.9% vs a year ago
Net income
−$275.1M
−27.1% margin
EPS (diluted)
−$16.41
Free cash flow
−$27.8M
−2.7% margin
Valuation
Market cap
$391.4M
17.1M shares
P/E
–
No P/E while losing money
Price to sales
0.4
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$10.1M
At Sep 30
Debt
$4.6B
At Sep 30
Shareholder equity
−$346.6M
Buybacks
$3.5M
Last 12 months
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $1.1B$1.1BFY2021FY2022: $1.1B$1.1BFY2022FY2023: $961.5M$961.5MFY2023FY2024: $930.6M$930.6MFY2024FY2025: $965.4M$965.4MFY2025

From CTEV's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 9). Last 12 months adds up the four latest quarters.

Last report
Aug 7
2026 · Before the open (BMO)
Reported EPS
-$3.49
vs -$4.10 est. · beat
Year-ago EPS
—
Not on file
Options-implied move
±23.0%
Priced in before that report
Analyst consensus
1 Buy
1 firm · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Buy
1firm
1 Buy0 Hold0 Sell
Only 1 firm rated CTEV in the past 90 days, not enough for a consensus
Average 12-month target
$40.00
▲ 74.5% upside

Based on 1 analyst who set a price target on CTEV in the past 90 days. The average target is $40.00, with a high of $40.00 and a low of $40.00, compared with the last close of $22.92.

Low $40.00Avg $40.00High $40.00
Blue marker: last close $22.92
Highest target$40.00
Average target$40.00
Lowest target$40.00
Latest rating changes
BarclaysTarget raised
Aug 21Buy$28 → $40
CitigroupMaintained
Aug 10Buy$45
Canaccord GenuityTarget raised
Aug 10Buy$37 → $43
Canaccord GenuityTarget raised
Jul 21Buy$32 → $37
Canaccord GenuityInitiated
May 29Buy$32
DateFirmActionRatingPrice target
Aug 21BarclaysTarget raisedBuy$28 → $40
Aug 10CitigroupMaintainedBuy$45
Aug 10Canaccord GenuityTarget raisedBuy$37 → $43
Jul 21Canaccord GenuityTarget raisedBuy$32 → $37
May 29Canaccord GenuityInitiatedBuy$32
Loading…

Technical Analysis

CTEV · as of the Nov 17 close · updated after every close
Downtrend

The stock is 4% below its 20 day and 12% below its 50 day average. It is 11% below its 200 day average, so the longer trend is down. Momentum is neutral (RSI 45). The nearest support is the Pivot S1 at $21.55, and the nearest resistance the Pivot at $23.45.

Short trendBearish
Long trendBearish
MomentumNeutral
StretchNormal
VolatilityHigh, 11.2%/day
Key levels
$55.5052 week high+142.1%
$28.91100 day average+26.1%
$25.6450 day average+11.9%
$25.42200 day average+10.9%
$24.91Swing high (Oct 29)+8.7%
$24.82Pivot R1+8.3%
$23.8520 day average+4.1%
$23.45Pivot+2.3%
$22.92Last close
$21.55Pivot S1−6.0%
$21.32Swing low (Oct 16)−7.0%
$11.5052 week low−49.8%
Indicators
RSI (14)44.78Middle of its rangeNeutral
MACD0.11Above its signal lineBullish
Stochastic52.5Middle of its rangeNeutral
ADX (14)19.4No clear trend
Williams %R-66.2Oversold below −80, overbought above −20Neutral
CCI (20)-21.0Oversold below −100, overbought above 100Neutral
Rate of change+8.8%Change over 10 sessionsBullish
ATR (14)$2.56Typical daily range, 11.2% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for CTEV

What happened before

See how CTEV did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Whale Options Flow

90D

No whale options trades in CTEV in the last 90 days.

Loading…

See today’s whale options flow across the market →

CTEV Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲62 buying vs 32 selling
  • ▼Held by funds -1.6 pts
  • ▲Funds holding +4
  • ▲Superinvestors: 4 added, 0 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding106102+3.9%
In funds' top 1067−14.3%
Held by funds88.8%90.4%−1.6 pts
New / increased16 / 4622 / 43−4.6%
Reduced / sold out20 / 1220 / 14−5.9%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See CTEV institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CTEV is in one of them and how their past CTEV trades turned out.

CTEV in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered CTEV in an article yet. Here's the latest on the wider market.

About Claritev

Claritev is a healthcare technology and data company based in McLean, Virginia. Its software and analytics help health insurers and other payers review claims before payment, control costs for care from providers outside their networks, manage provider networks and find billing errors. Its direct customers are mainly payers, including administrative services platforms and third party administrators, which offer its solutions to employers, plan sponsors and their members. The services run on a shared platform that connects to clients' systems.

Headquarters
Mclean, VA